Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,485 | -$8,202 | -$11,732 | -$6,826 |
| Dep. & Amort. | $382 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,447 | $0 | $885 | $0 |
| Change in WC | $306 | -$799 | $1,164 | $908 |
| Other Non-Cash | $0 | $910 | $0 | $481 |
| Operating Cash Flow | -$6,350 | -$8,091 | -$9,683 | -$5,437 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $14,883 | -$62 | $6,647 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$265 | $0 |
| Financing Cash Flow | $14,883 | -$62 | $6,382 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8,534 | -$8,153 | -$3,301 | -$5,437 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,094 | $11,247 | $14,548 | $19,986 |
| End Cash | $11,628 | $3,094 | $11,247 | $14,548 |
| Free Cash Flow | -$6,350 | -$8,091 | -$9,683 | -$5,437 |